Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 24, 2024 07:08 ET
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase during the 2024 Angel Capital Association (ACA) Summit. This event marks a significant step for...
Apr 24, 2024 07:05 ET
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the treatment of adults with primary IgA nephropathy (IgAN)...
Apr 24, 2024 07:01 ET
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company has received clearance from the U.S. Food and Drug Administration...
Apr 24, 2024 07:00 ET
Rogers Communications Reports First Quarter 2024 Results
Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) today announced its unaudited financial and operating results for the first quarter ended March 31, 2024. "We continued to deliver industry-leading growth in the first quarter, our...
Apr 24, 2024 07:00 ET
Shenandoah Telecommunications Company to Hold its First Quarter 2024 Earnings Call at 8:30 a.m. on Friday, May 3, 2024
Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024, and will host a conference call and simultaneous webcast on the same day at 8:30...
Apr 24, 2024 07:00 ET
Smart Share Global Limited Files Its Annual Report on Form 20-F
Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023...
Apr 24, 2024 07:00 ET
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the first patient has been dosed in Part 2 of Beckley Psytech’s...
Apr 24, 2024 07:00 ET
Alts Marketplace Unveils Latest Developments in Alternative Investments
Alts Marketplace, a division of Formidium Corp, is pleased to announce significant advancements in the realm of alternative investments. Positioned as a pioneering force in this evolving landscape, Alts Marketplace continues to shape the future of...
Apr 24, 2024 07:00 ET
Rogers Communications Declares 50 Cents per Share Quarterly Dividend
Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“Rogers”) announced that its Board of Directors declared a quarterly dividend totaling 50 cents per share (the “Quarterly Dividend”) on each of its outstanding Class B Non-Voting shares...
Apr 24, 2024 07:00 ET
Company Commences Oil Sales from California Assets
Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, today provided updates on its petroleum assets in Monterey County, California, and Uintah County, Utah. The Company this week will...
Apr 24, 2024 07:00 ET
Aduro Clean Technologies Joins Delegation at Intergovernmental Negotiating Committee on Plastic Pollution (INC-4)
Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils,...
Apr 24, 2024 07:00 ET
Alta Equipment Group Announces Date of First Quarter 2024 Financial Results Release, Conference Call and Webcast
Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or “the Company”), a leading provider of premium material handling, construction and environmental processing equipment and related services, today announced that it will report its financial results...
Apr 24, 2024 07:00 ET
Asante Gold Announces Results of Annual General Meeting of Shareholders
Asante Gold Corporation (“Asante” or the “Company” CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) announces the results of its annual general meeting of shareholders (the "Meeting") held yesterday, April 23, 2024. A total of 288,306,101 common...
Apr 24, 2024 07:00 ET
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on eblasakimab in Chronic Obstructive...
Apr 24, 2024 07:00 ET
ATHA Energy Agrees to Terms on $8 Million Option Agreement With Inspiration Energy for Plateau and Ledge Properties
ATHA Energy Corp. (TSX.V: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio in two of the highest-grade uranium districts in the world, is pleased to announce it has entered into an...
Apr 24, 2024 07:00 ET
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated,...
Apr 24, 2024 07:00 ET
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases
Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration...
Apr 24, 2024 07:00 ET
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report its first quarter 2024...
Apr 24, 2024 07:00 ET
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast...
Apr 24, 2024 07:00 ET
CRN Honors Striim With a Spot on Its 2024 Big Data 100 List
Striim, the Industry’s First AI-powered Intelligent Integration Platform, announced today that CRN®, a brand of The Channel Company®, included Striim on its 2024 Big Data 100 list in the Big Data Management and Integration Tools category. This...